$CORZ

DUCHENE TODD M sold $226K of CORZ

DUCHENE TODD M (See remarks) sold 10,000 shares of Core Scientific, Inc./tx (CORZ) at $22.63 ($0.23M total) on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DUCHENE TODD M
Published Jul 8, 2026, 8:32 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CORZ
Neutral
high confidence
Mentioned
$CORZ
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CORZNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and that it was executed under a pre-arranged 10b5-1 plan; the text does not include any new company fundamentals.

02

Market read

Primarily confirms insider liquidity activity; limited incremental trading edge absent other catalysts.

03

What to watch

The article provides no context on why the sale occurred, whether other insiders sold, or whether there were concurrent company disclosures; those factors would matter more than the sale size alone.

Relevance 3/10Novelty 3/10Timing: Filed 2026-07-08, reflecting a sale executed 2026-07-06.

Background

This is an SEC Form 4 insider transaction disclosure for Core Scientific, Inc.

Company-level read

Ticker impact

$CORZNeutralHigh confidence
Context

SEC Form 4 shows officer DUCHENE TODD M sold 10,000 shares of Core Scientific at $22.6254 on 2026-07-06 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is a scheduled open-market sale (10b5-1) with no accompanying operational, financial, or regulatory catalyst described in the text.

Market effects

Minimal, as the disclosure is company-specific insider trading without sector-wide information.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with perceived risk, so traders may watch for follow-on insider activity or changes in guidance not mentioned here.

Key entities

  • Core Scientific, Inc.

    Subject of the Form 4 insider transaction disclosure (CORZ).

  • DUCHENE TODD M

    Officer who sold 10,000 shares under a 10b5-1 plan.

Related articles

$CORZMedAI 8/10

Core Scientific lands USD$14B AMD AI infrastructure partnership

Core Scientific (CORZ) said it signed a 15-year AI infrastructure partnership with AMD (AMD) covering 529 MW of U.S. capacity, with potential contracted revenue above $14B. AMD can reserve an additional 1,925 MW through Dec. 28, 2028, deploying from 2027. Warrants allow AMD to buy up to 30M CORZ shares at $23.47.

$AMDMed

AMD's Core Scientific deal is bigger than the headline number

Nine months ago, Core Scientific shareholders turned down real money. They rejected a $9 billion buyout offer from CoreWeave, according to CNBC. Shareholders bet the company was worth more standing alone. On Tuesday, that bet started to look prescient. AMD agreed to lease more than 500 megawatts of Core Scientific's U.S. data center capacity, according to a press release from the companies. The stock market did not treat the news as a simple win for either side.